Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 138.75

+0.8%

3:44 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: B.D. who wrote (43)	6/20/1997 8:11:00 AM
From: Dr. John M. de Castro	of 1834

I agree. The three lock-ups have expired with minimal insider trading. Of course there will be minor selling from time to time as insiders need cash to buy their yachts :-) However, I read the minimal activity as an endorsement by the insiders of the future of NBIX. Can anyone explain to me how they intend to make money on DHEA. Even if it is effective and approved for Alzheimers, DHEA is easilly obtained everywhere at minimal cost. Why would NBIX be spending money on running clinical trials ??? John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next